Reimbursement

During American Pharmacists Month, and as the country uses all available health care resources to address COVID-19, there has never been a better or more important time to grant provider status to pharmacists.

An overview of arrangements that pharmacies enter into that violate the federal anti-kickback statute.

A study published in The Lancet Public Health found that modifiable health risks, such as obesity, high blood pressure, and smoking, were linked to more than $730 billion in health care spending in the United States in 2016.

The Provider Relief Fund, as part of the CARES Act, was an important stopgap for many health care providers across the country, but details on reporting requirements and timing have been elusive.

Technology can help revolutionize how a pharmacy manages patients, collects payments, communicates, and can improve overall efficiency.

Protections for covered entities under the 340B program will most likely be affected by decisions in the Senate.

Data standardization has been an ongoing problem in the specialty pharmacy field, affecting both patients and providers when approaching treatments.

During the COVID-19 pandemic, many families and individuals have not been able to pay their out-of-pocket costs or do not have enough money saved to pay their deductibles.

Researchers found that although the number of Medicare beneficiaries increased between 2014 and 2018, total costs decreased.

The terms of participation in the phase 2 round of the Provider Relief Fund created an unintended exclusion for pharmacies that primarily serve Medicaid/Children’s Health Insurance Program patients.

Racial and economic disparities are especially pronounced among patients on Medicare, study shows.

The goals of specialty pharmacy programs are to reduce or delay progression of the disease, improve patient outcomes, enhance patients’ quality of life, keep patients in the workforce longer, and decrease total health care costs.

With election season intensifying, 35% of voters said drug pricing is among the most important issues influencing their vote in November.

More than 40 million unemployment claims have been filed over the course of the COVID-19 pandemic.

NACDS states that although prescription drug discount cards were put in place to reduce out-of-pocket costs, states have been using the data in a manner inconsistent with federal law and policy.

National Association of Chain Drug Stores joins with 20 other groups in asking Congress to take action that includes designating pharmacists as providers under Medicare.

A new study found that Medicare Part D prescription drug insurance plans largely favor generic drugs over brand-name counterparts, despite previous reports to the contrary.

Vizient report shows that the COVID-19 pandemic resulted in a $200 million increase in the top 10 COVID-related drugs, as well as a decrease in vaccinations between March and April.

The investigators noted that the shift toward value-based care has placed a greater emphasis on preventive care and chronic disease management services as delivered by multidisciplinary health care teams.

Representatives from the organizations spoke with HHS last week before President Donald Trump signed several executive orders, including one that would address manufacturer rebates also collected by PBMs.

As legislators debate the next stimulus package, pharmacists are expressing dismay that the current language does not include designating pharmacists as providers under Medicare Part B for COVID-19 testing and immunization.

Individuals covered via high-deductible health care plans not found to have a greater risk of heart attack or stroke.

Long-term care (LTC) pharmacies caring for this population face a myriad of unique obstacles, especially the regulatory framework surrounding them.

How a pharmacy performs with respect to specific measures can be associated with a DIR fee.

New ruling means up to 126,400 women of childbearing age may need to pay out-of-pocket for birth control.